{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:38:52Z","timestamp":1776836332900,"version":"3.51.2"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Long non-coding RNAs (lncRNAs) participate in pathogenesis, progression and therapy resistance in multiple myeloma (MM). Growth Arrest-Specific 5 (\n                      <jats:italic>GAS5<\/jats:italic>\n                      ) is a lncRNA with a role in proliferation, invasion and metastasis in solid tumors, but prognostic significance in MM is unknown so far. Aim: The purpose of this study was to examine the expression pattern of\n                      <jats:italic>GAS5<\/jats:italic>\n                      lncRNA in plasma samples of MM patients and to evaluate its clinical and prognostic significance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and material<\/jats:title>\n                    <jats:p>\n                      73 newly diagnosed patients with MM and 16 healthy volunteers were recruited from Clinical Hospital Centre (CHC) \u201cBe\u017eanijska Kosa\u201d and CHC \u201cZemun\u201d in the period from July 2020 to December 2024. Blood samples were collected before starting therapy. Demographic, laboratory and clinical parameters, prognostic score, overall response rate, progression free survival (PFS) and overall survival (OS) were analyzed. Relative quantification analysis of the\n                      <jats:italic>GAS5<\/jats:italic>\n                      expression level was performed by RQ-PCR methodology with the\n                      <jats:italic>GAPDH<\/jats:italic>\n                      gene as endogenous control and by using the comparative ddCt method with control samples as a calibrator.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      No significant difference was found between plasma expression\n                      <jats:italic>GAS5<\/jats:italic>\n                      in MM patients (median 0.833, range 0.013-3.678) and\n                      <jats:italic>GAS5<\/jats:italic>\n                      expression in healthy control samples (median 1, range 0.49-2.668) (p=0.116). In multivariate analysis with PFS as the dependent variable, higher\n                      <jats:italic>GAS5<\/jats:italic>\n                      expression and advanced age were associated with shorter time to progression, while higher R2-ISS score, advanced age and occurrence of relapse\/progression of disease were independent prognostic factors for survival in our group of patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This is the first study showing prognostic potential of circulating lncRNA\n                      <jats:italic>GAS5<\/jats:italic>\n                      in the MM patients. Patients with MM had a slightly lower\n                      <jats:italic>GAS5<\/jats:italic>\n                      expression compared to control samples, this was, nevertheless, without statistical significance. In patients with higher GAS5 expression disease progression occurred earlier compared to patients with lower expression. To establish\n                      <jats:italic>GAS5<\/jats:italic>\n                      as a robust biomarker in MM, future studies should focus on larger patient cohorts to validate its expression within the bone marrow niche and its specific association with high-risk \u2018double-hit\u2019 cytogenetic aberrations and glucocorticoid resistance.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1791554","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:41:16Z","timestamp":1776832876000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma expression of long non-coding RNA GAS5 and its prognostic significance in newly diagnosed multiple myeloma"],"prefix":"10.3389","volume":"16","author":[{"given":"Anica","family":"Pravdic Divac","sequence":"first","affiliation":[{"name":"Department of Hematology, University Clinical-Hospital center \u201cBezanijska kosa\u201d","place":["Belgrade, Serbia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasa","family":"Tosic","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering, University of Belgrade","place":["Belgrade, Serbia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zorica","family":"Cvetkovic","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Clinical-Hospital center Zemun","place":["Belgrade, Serbia"]},{"name":"Faculty of Medicine, University of Belgrade","place":["Belgrade, Serbia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Radulovic","sequence":"additional","affiliation":[{"name":"Clinic for Neurosurgery, University Clinical Center of Serbia","place":["Belgrade, Serbia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodora","family":"Karan-Djurasevic","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering, University of Belgrade","place":["Belgrade, Serbia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Tomic","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Clinical-Hospital center Zemun","place":["Belgrade, Serbia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Marjanovic","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering, University of Belgrade","place":["Belgrade, Serbia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasa","family":"Stanisavljevic","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Clinical-Hospital center \u201cBezanijska kosa\u201d","place":["Belgrade, Serbia"]},{"name":"Faculty of Medicine, University of Belgrade","place":["Belgrade, Serbia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branka","family":"Zukic","sequence":"additional","affiliation":[{"name":"Institute of Molecular Genetics and Genetic Engineering, University of Belgrade","place":["Belgrade, Serbia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivera","family":"Markovic","sequence":"additional","affiliation":[{"name":"Department of Hematology, University Clinical-Hospital center \u201cBezanijska kosa\u201d","place":["Belgrade, Serbia"]},{"name":"Faculty of Medicine, University of Belgrade","place":["Belgrade, Serbia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"B1","unstructured":"2022 estimates\n          \n          2022"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02515","article-title":"Long-term follow-up results of lenalidomide, bortezomib, and dexamethasone induction therapy and risk-adapted maintenance approach in newly diagnosed multiple myeloma","volume":"38","author":"Joseph","year":"2020","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.11.014","article-title":"Multiple myeloma: EHA-ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Dimopoulos","year":"2021","journal-title":"Ann Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2023.2258686","article-title":"The age-dependent changes in risk weights of the prognostic factors for multiple myeloma","volume":"28","author":"Du","year":"2023","journal-title":"Hematology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061285","article-title":"Multiple myeloma: Heterogeneous in every way","volume":"13","author":"Schavgoulidze","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112767","article-title":"The role of epigenetics in the development and progression of multiple myeloma","volume":"10","author":"Ismail","year":"2022","journal-title":"Biomedicines"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2017.09.007","article-title":"Epigenetics in multiple myeloma: From mechanisms to therapy","volume":"51","author":"Alzrigat","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41389-025-00579-w","article-title":"Investigation of lncRNA expression in newly diagnosed multiple myeloma reveals a LINC01432-CELF2 axis as an inhibitor of apoptosis","volume":"14","author":"Mishra","year":"2025","journal-title":"Oncogenesis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102996","article-title":"Epigenetic aberrations in multiple myeloma","volume":"12","author":"Caprio","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.03.010","article-title":"Long noncoding RNAs in cancer pathways","volume":"29","author":"Schmitt","year":"2016","journal-title":"Cancer Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3892\/ijo.2023.5517","article-title":"Long non-coding RNAs in multiple myeloma (review)","volume":"62","author":"Yang","year":"2023","journal-title":"Int J Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.12.8.3514-3521.1992","article-title":"Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation, and development","volume":"12","author":"Coccia","year":"1992","journal-title":"Mol Cell Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2795(199711)48:3<310::AID-MRD2>3.0.CO;2-U","article-title":"The growth arrest genes gas5, gas6, and CHOP-10 (gadd153) are expressed in the mouse preimplantation embryo","volume":"48","author":"Fleming","year":"1997","journal-title":"Mol Reprod Dev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(88)91065-3","article-title":"Genes specifically expressed at growth arrest of mammalian cells","volume":"54","author":"Schneider","year":"1988","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.12.6897","article-title":"Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5'-terminal oligopyrimidine gene family reveals common features of snoRNA host genes","volume":"18","author":"Smith","year":"1998","journal-title":"Mol Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098561","article-title":"Growth arrest-specific transcript 5 associated snoRNA levels are related to p53 expression and DNA damage in colorectal cancer","volume":"9","author":"Krell","year":"2014","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2000568","article-title":"Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor","volume":"3","author":"Kino","year":"2010","journal-title":"Sci Signal"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-16-0331","article-title":"LncRNA GAS5 inhibits cellular proliferation by targeting P27Kip1","volume":"15","author":"Luo","year":"2017","journal-title":"Mol Cancer Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.11809","article-title":"Long non-coding RNA GAS5 in human cancer","volume":"20","author":"Yang","year":"2020","journal-title":"Oncol Lett"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2013.05.005","article-title":"Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines","volume":"1832","author":"Pickard","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2016.3377","article-title":"Lentiviral-mediated overexpression of long non-coding RNA GAS5 reduces invasion by mediating MMP2 expression and activity in human melanoma cells","volume":"48","author":"Chen","year":"2016","journal-title":"Int J Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2018.08.032","article-title":"Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5","volume":"151","author":"Zhao","year":"2018","journal-title":"Gynecol Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2018.09.026","article-title":"lncRNA GAS5 reverses EMT and tumor stem cell-mediated gemcitabine resistance and metastasis by targeting miR-221\/SOCS3 in pancreatic cancer","volume":"13","author":"Liu","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6584","article-title":"lncRNA GAS5 inhibits colorectal cancer cell proliferation via the miR-182-5p\/FOXO3a axis","volume":"40","author":"Cheng","year":"2018","journal-title":"Oncol Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000433499","article-title":"GAS5 inhibits gastric cancer cell proliferation partly by modulating CDK6","volume":"38","author":"Guo","year":"2015","journal-title":"Oncol Res Treat"},{"key":"B26","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1002\/mc.22120","article-title":"A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer","volume":"54","author":"Shi","year":"2015","journal-title":"Mol Carcinog"},{"key":"B27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ygyno.2019.10.025","article-title":"The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system","volume":"156","author":"McComas","year":"2020","journal-title":"Gynecol Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41419-018-0264-z","article-title":"Long non-coding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-025-01459-4","article-title":"Oncogenic function of growth arrest-specific transcript 5 by competing with miR-423-3p to regulate SMARCA4 in hepatocellular carcinoma","volume":"57","author":"Kim","year":"2025","journal-title":"Exp Mol Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-20-2221","article-title":"Gain of GAS5 reveals worse prognosis in kidney renal clear cell carcinoma and liver hepatocellular carcinoma from the Cancer Genome Atlas dataset","volume":"10","author":"Li","year":"2021","journal-title":"Transl Cancer Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40364-020-00194-4","article-title":"Circulating long non-coding RNA GAS5 (growth arrest-specific transcript 5) as a complement marker for the detection of Malignant mesothelioma using liquid biopsies","volume":"8","author":"Weber","year":"2020","journal-title":"biomark Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S297868","article-title":"Long noncoding RNA GAS5 accelerates cholangiocarcinoma progression by regulating hsa-miR-1297","volume":"13","author":"Li","year":"2021","journal-title":"Cancer Manag Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12010086","article-title":"Expression profiles of long non-coding RNA GAS5 and microRNA-222 in younger AML patients","volume":"12","author":"Pavlovic","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1038\/s41598-021-81715-5","article-title":"Circulating long non-coding RNAs HOTAIR, Linc-p21, GAS5 and XIST expression profiles in diffuse large B-cell lymphoma: Association with R-CHOP responsiveness","volume":"11","author":"Senousy","year":"2021","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194744","article-title":"Increased plasma levels of lncRNAs LINC01268, GAS5 and MALAT1 correlate with negative prognostic factors in myelofibrosis","volume":"13","author":"Fantini","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13236064","article-title":"Overexpression of the GR riborepressor lncRNA GAS5 results in poor treatment response and early relapse in childhood B-ALL","volume":"13","author":"Xagorari","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2014.02.010","article-title":"Investigation of circulating lncRNAs in B-cell neoplasms","volume":"431","author":"Isin","year":"2014","journal-title":"Clin Chim Acta"},{"key":"B38","article-title":"Value of long chain non-coding RNA crnde-h and gas5 in predicting the prognosis of multiple myeloma","volume":"28","author":"Li","year":"2017","journal-title":"Biomed Res (India)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised international staging system for multiple myeloma: A report from international myeloma working group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J Clin Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02614","article-title":"Second revision of the International Staging System (R2-ISS) for overall survival in multiple myeloma: A European Myeloma Network (EMN) report within the HARMONY Project","volume":"40","author":"D'Agostino","year":"2022","journal-title":"J Clin Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27422","article-title":"Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management","volume":"99","author":"Rajkumar","year":"2024","journal-title":"Am J Hematol"},{"key":"B43","volume-title":"Multipli Mijelom \u2013 Predlog Dijagnosti\u010dkih i Terapijskih Vodi\u010da SMG 2022 (Peto izdanje)","year":"2022"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar","year":"2016","journal-title":"Lancet Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-10-299487","article-title":"International Myeloma Workshop Consensus Panel 1. Consensus recommendations for the uniform reporting of clinical trials: Report of the International Myeloma Workshop Consensus Panel 1","volume":"117","author":"Rajkumar","year":"2011","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-14-3","article-title":"Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma","volume":"14","author":"Tong","year":"2015","journal-title":"Mol Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7439698","article-title":"Identification of circulating long noncoding RNA Linc00152 as a novel biomarker for diagnosis and monitoring of non-small-cell lung cancer","volume":"2017","author":"Li","year":"2017","journal-title":"Dis Markers"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-809","article-title":"MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression","volume":"14","author":"Cho","year":"2014","journal-title":"BMC Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3233\/cbm-190246","article-title":"Long non-coding RNA GAS5 regulates human B lymphocytic leukaemia tumourigenesis and metastasis by sponging miR-222","volume":"26","author":"Jing","year":"2019","journal-title":"Cancer biomark"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna8030039","article-title":"Tumor suppressive effects of GAS5 in cancer cells","volume":"8","author":"Kaur","year":"2022","journal-title":"Noncoding RNA"},{"key":"B51","doi-asserted-by":"publisher","first-page":"469","DOI":"10.5114\/aoms.2020.98815","article-title":"Expression pattern of circulating long non-coding RNA GAS5 as a novel biomarker in non-small cell lung cancer patients","volume":"22","author":"Vesovic","year":"2026","journal-title":"Arch Med Sci"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4189-1","article-title":"Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy","volume":"37","author":"Fayda","year":"2016","journal-title":"Tumour Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.77527","article-title":"The multifaceted role of lncRNA GAS5: A pan-cancer analysis of its diagnostic, prognostic, and therapeutic potential","volume":"17","author":"Eisa","year":"2025","journal-title":"Cureus"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2174\/1566524015666150114122354","article-title":"Long noncoding RNA GAS5: A novel marker involved in glucocorticoid response","volume":"15","author":"Lucafo","year":"2015","journal-title":"Curr Mol Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-20-213","article-title":"Long non-coding RNA growth arrest specific-5: a potential biomarker for early diagnosis of severe asthma","volume":"12","author":"Wu","year":"2020","journal-title":"J Thorac Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.11.028","article-title":"Age is a prognostic factor for the overall survival of patients with multiple myeloma undergoing upfront autologous hematopoietic stem cell transplantation","volume":"26","author":"Cordas Dos Santos","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.70012","article-title":"Determinants of 15-year progression-free survival in multiple myeloma; real-world data from a single institution","volume":"100","author":"Dimopoulos","year":"2025","journal-title":"Am J Hematol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.288041","article-title":"The impact of age on survival and excess mortality after autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients","volume":"111","author":"Mizuno","year":"2026","journal-title":"Haematologica"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2017.1365859","article-title":"Managing multiple myeloma in elderly patients","volume":"59","author":"Diamond","year":"2018","journal-title":"Leuk Lymphoma"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1791554\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:41:24Z","timestamp":1776832884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1791554\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":59,"alternative-id":["10.3389\/fonc.2026.1791554"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1791554","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"1791554"}}